Fibrotic microtissue array to predict anti-fibrosis drug efficacy

A bottleneck in developing new anti-fibrosis therapies is the absence of suitable in vitro models that recapitulate key features of fibrogenesis. Here the authors develop a tissue-on-a-chip model of lung fibrosis and test the therapeutic efficacy of two recent FDA-approved drugs.

Bibliographic Details
Main Authors: Mohammadnabi Asmani, Sanjana Velumani, Yan Li, Nicole Wawrzyniak, Isaac Hsia, Zhaowei Chen, Boris Hinz, Ruogang Zhao
Format: Article
Language:English
Published: Nature Publishing Group 2018-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-018-04336-z
id doaj-6ac76a78833f45c899ebfb821c22460e
record_format Article
spelling doaj-6ac76a78833f45c899ebfb821c22460e2021-05-11T10:32:59ZengNature Publishing GroupNature Communications2041-17232018-05-019111210.1038/s41467-018-04336-zFibrotic microtissue array to predict anti-fibrosis drug efficacyMohammadnabi Asmani0Sanjana Velumani1Yan Li2Nicole Wawrzyniak3Isaac Hsia4Zhaowei Chen5Boris Hinz6Ruogang Zhao7Department of Biomedical Engineering, University at Buffalo, The State University of New YorkDepartment of Biomedical Engineering, University at Buffalo, The State University of New YorkDepartment of Biomedical Engineering, University at Buffalo, The State University of New YorkDepartment of Biomedical Engineering, University at Buffalo, The State University of New YorkDepartment of Biomedical Engineering, University at Buffalo, The State University of New YorkDepartment of Biomedical Engineering, University at Buffalo, The State University of New YorkLaboratory of Tissue Repair and Regeneration, Matrix Dynamics Group, Faculty of Dentistry, University of TorontoDepartment of Biomedical Engineering, University at Buffalo, The State University of New YorkA bottleneck in developing new anti-fibrosis therapies is the absence of suitable in vitro models that recapitulate key features of fibrogenesis. Here the authors develop a tissue-on-a-chip model of lung fibrosis and test the therapeutic efficacy of two recent FDA-approved drugs.https://doi.org/10.1038/s41467-018-04336-z
collection DOAJ
language English
format Article
sources DOAJ
author Mohammadnabi Asmani
Sanjana Velumani
Yan Li
Nicole Wawrzyniak
Isaac Hsia
Zhaowei Chen
Boris Hinz
Ruogang Zhao
spellingShingle Mohammadnabi Asmani
Sanjana Velumani
Yan Li
Nicole Wawrzyniak
Isaac Hsia
Zhaowei Chen
Boris Hinz
Ruogang Zhao
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
Nature Communications
author_facet Mohammadnabi Asmani
Sanjana Velumani
Yan Li
Nicole Wawrzyniak
Isaac Hsia
Zhaowei Chen
Boris Hinz
Ruogang Zhao
author_sort Mohammadnabi Asmani
title Fibrotic microtissue array to predict anti-fibrosis drug efficacy
title_short Fibrotic microtissue array to predict anti-fibrosis drug efficacy
title_full Fibrotic microtissue array to predict anti-fibrosis drug efficacy
title_fullStr Fibrotic microtissue array to predict anti-fibrosis drug efficacy
title_full_unstemmed Fibrotic microtissue array to predict anti-fibrosis drug efficacy
title_sort fibrotic microtissue array to predict anti-fibrosis drug efficacy
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2018-05-01
description A bottleneck in developing new anti-fibrosis therapies is the absence of suitable in vitro models that recapitulate key features of fibrogenesis. Here the authors develop a tissue-on-a-chip model of lung fibrosis and test the therapeutic efficacy of two recent FDA-approved drugs.
url https://doi.org/10.1038/s41467-018-04336-z
work_keys_str_mv AT mohammadnabiasmani fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT sanjanavelumani fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT yanli fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT nicolewawrzyniak fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT isaachsia fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT zhaoweichen fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT borishinz fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
AT ruogangzhao fibroticmicrotissuearraytopredictantifibrosisdrugefficacy
_version_ 1721447946781720576